HBSP (USA)
-
Empire Glass Co. (A) (Spanish Version)
Hawkins, David F.Case HBS-106S11Accounting and ControlSe refiere a control de gestión a nivel de división, y el uso de los presupuestos.Starting at €8.20
-
The TELUS Share Conversion Proposal
White, Lucy; Esty, Benjamin C.; Mazzanti, LisaCase HBS-214001-EFinanceOn February 21, 2013, TELUS announced a proposal to convert the firm's non-voting shares into voting shares on a one-to-one basis, thereby eliminating the firm's dual class structure. Shareholders were scheduled to vote on the proposal at the firm's annual general meeting (AGM) on May 9, 2013. Despite strong support from management, the board, two proxy advisory firms, and several large shareholders, the proposal was opposed by Mason Capital Mana...Starting at €8.20
-
Molycorp: Financing the Production of Rare Earth Minerals (A)
Esty, Benjamin C.; Mayfield, E. ScottCase HBS-214054-EFinanceMolycorp, the western hemisphere's only producer of rare earth minerals, was in the middle of a $1 billion capital expenditure project in its effort to become a vertically integrated supplier of rare earth minerals, oxides, and metals. Yet it had just repStarting at €8.20
-
Molycorp: Morgan Brothers' Reverse Convertible Notes (C)
Esty, Benjamin C.; Mayfield, E. ScottCase HBS-215002-EFinanceIn August 2011, Morgan Brothers Bank was issuing a $2.5 million reverse convertible note with payoffs linked to the price of Molycorp's common stock. These financially engineered securities were just one of many kinds of structured notes available in the retail market. Investors must decide whether the notes were fairly priced and whether they offered a favorable risk-return trade-off.Starting at €5.74
-
Thomas Cook Group on the Brink (B): Transformation Year 1 Results
Esty, Benjamin C.Case HBS-215051-EFinanceAnalyzes the results of the Thomas Cook turnaround plan after the first year under Harriet Green's leadership (November 2013).Starting at €5.74
-
The De Beers Group: Launching Lightbox Jewelry for Lab-Grown Diamonds
Esty, Benjamin C.Case HBS-719408-EStrategyIn May 2018, the De Beers Group shocked the diamond industry when it announced it was launching a new fashion jewelry brand of laboratory-grown (synthetic) diamonds. The reaction was swift as people sought to understand the company's motivations: was it a "huge gamble" or a "Machiavellian masterstroke"? What was the objective of the new product launch, would it succeed, and how would this new business affect the Group's core business of selling n...Starting at €8.20
-
SKA (Suecia)
Hawkins, David F.Case HBS-109S03Accounting and ControlLa administración está debatiendo una propuesta para sacar provecho de I + D. Mientras sueca PCGA permite la capitalización, la práctica general es a gastos de I + D que se incurren.Starting at €8.20
-
The De Beers Group: Exploring the Diamond Reselling Opportunity
Esty, Benjamin C.; Gross, Daniel P.; Pickle, Lauren G.Case HBS-717430-EStrategyIn September 2014, Tom Montgomery (SVP of strategic initiatives at the De Beers Group) and his team launched a pilot program in the United States to explore the $1 billion diamond market for pre-owned (recycled) diamonds. According to Montgomery, the motivation for the pilot program was to improve the consumer reselling experience and to enhance "diamond equity". Somewhat paradoxically, consumers typically received very low prices when they tried...Starting at €8.20
-
Thomas Cook Group on the Brink (C): Transformation Year 2 Results
Esty, Benjamin C.Case HBS-215052-EFinanceAnalyzes the results of the Thomas Cook turnaround plan after the second year under Harriet Green's leadership (November 2014).Starting at €5.74
-
Bayer AG: Bidding to Win Merck's OTC Business
Esty, Benjamin C.; Baaij, Marc; Mulder, ArjenCase HBS-217021-EFinanceShortly after submitting their best and final offer to acquire Merck's Consumer Care Division, a collection of "over-the-counter" (OTC) products with sales totaling $2 billion, the Bayer M&A team was given a chance to revise their bid because another potential acquirer - likely Reckitt-Benckiser, a UK based company that had outbid them in a few prior acquisition auctions - had submitted a last-minute offer to Merck. Frank Rittgen (Head of M&A) an...Starting at €8.20